151 related articles for article (PubMed ID: 22243476)
1. Proteomics signature profiling (PSP): a novel contextualization approach for cancer proteomics.
Goh WW; Lee YH; Ramdzan ZM; Sergot MJ; Chung M; Wong L
J Proteome Res; 2012 Mar; 11(3):1571-81. PubMed ID: 22243476
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies.
Goh WW; Fan M; Low HS; Sergot M; Wong L
BMC Genomics; 2013 Jan; 14():35. PubMed ID: 23324392
[TBL] [Abstract][Full Text] [Related]
3. Network-based pipeline for analyzing MS data: an application toward liver cancer.
Goh WW; Lee YH; Zubaidah RM; Jin J; Dong D; Lin Q; Chung MC; Wong L
J Proteome Res; 2011 May; 10(5):2261-72. PubMed ID: 21410269
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
[TBL] [Abstract][Full Text] [Related]
5. A network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression.
Goh WW; Lee YH; Ramdzan ZM; Chung MC; Wong L; Sergot MJ
Int J Bioinform Res Appl; 2012; 8(3-4):155-70. PubMed ID: 22961449
[TBL] [Abstract][Full Text] [Related]
6. Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases.
Zhu XD; Li CL; Lang ZW; Gao GF; Tien P
World J Gastroenterol; 2004 Apr; 10(8):1141-5. PubMed ID: 15069714
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
[TBL] [Abstract][Full Text] [Related]
8. Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.
Yang L; Rong W; Xiao T; Zhang Y; Xu B; Liu Y; Wang L; Wu F; Qi J; Zhao X; Wang H; Han N; Guo S; Wu J; Gao Y; Cheng S
Sci China Life Sci; 2013 Jul; 56(7):638-46. PubMed ID: 23749381
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
Gao H; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Qin R; Yan L; Xiao G
Oncotarget; 2017 Jan; 8(3):4289-4300. PubMed ID: 28008144
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.
Niu Y; Wu Z; Shen Q; Song J; Luo Q; You H; Shi G; Qin W
Dig Liver Dis; 2013 Dec; 45(12):1041-8. PubMed ID: 23891548
[TBL] [Abstract][Full Text] [Related]
12. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
13. Enhanced peptide quantification using spectral count clustering and cluster abundance.
Lee S; Kwon MS; Lee HJ; Paik YK; Tang H; Lee JK; Park T
BMC Bioinformatics; 2011 Oct; 12():423. PubMed ID: 22034872
[TBL] [Abstract][Full Text] [Related]
14. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma.
Lee ES; Han EM; Kim YS; Shin BK; Kim CH; Kim HK; Won NH; Yeom BW; Kim I; Leong AS
Am J Clin Pathol; 2005 Jul; 124(1):31-6. PubMed ID: 15923163
[TBL] [Abstract][Full Text] [Related]
16. Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis.
Liu S; Zhu P; Zhang L; Ding S; Zheng S; Wang Y; Lu F
Cancer Biomark; 2013; 13(5):345-9. PubMed ID: 24440974
[TBL] [Abstract][Full Text] [Related]
17. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.
Göbel T; Vorderwülbecke S; Hauck K; Fey H; Häussinger D; Erhardt A
World J Gastroenterol; 2006 Dec; 12(47):7604-12. PubMed ID: 17171788
[TBL] [Abstract][Full Text] [Related]
18. [Expression of MCP/CCR2 in patients of hepatocellular carcinoma and liver cirrhosis].
Fang N; Fan X; Zhang XS
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):553-4. PubMed ID: 19912695
[No Abstract] [Full Text] [Related]
19. Proteomics in the study of liver pathology.
Parent R; Beretta L
J Hepatol; 2005 Jul; 43(1):177-83. PubMed ID: 15894398
[No Abstract] [Full Text] [Related]
20. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
Liu CC; Wang YH; Chuang EY; Tsai MH; Chuang YH; Lin CL; Liu CJ; Hsiao BY; Lin SM; Liu LY; Yu MW
Mol Carcinog; 2014 Jan; 53(1):58-66. PubMed ID: 22911910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]